Related Experiment Video
Updated: Aug 16, 2026

A Miniaturized Glycan Microarray Assay for Assessing Avidity and Specificity of Influenza A Virus Hemagglutinins
Published on: May 29, 2016
Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G
S A Feldman1, R M Hendry, J A Beeler
1Laboratory of Pediatric and Respiratory Virus Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA. feldmans@cber.fda.gov
Insights
Respiratory syncytial virus (RSV) attachment protein G binds heparin via a specific domain, crucial for infection. This heparin-binding domain (HBD) on RSV G protein is key to viral entry and infectivity.
Area of Science:
- Virology
- Glycobiology
- Molecular Biology
Background:
- Respiratory syncytial virus (RSV) causes significant lower respiratory tract disease in young children globally.
- RSV infection involves initial attachment protein (G) interaction with cell surface heparin-like glycosaminoglycans (Gag).
Purpose of the Study:
- To identify and characterize the heparin-binding domain (HBD) of the RSV G protein.
- To investigate the role of this HBD in viral attachment and infectivity.
Main Methods:
- Synthetic peptides from RSV G protein ectodomain were tested for heparin binding using heparin-agarose affinity chromatography.
- Peptide binding was assessed on Vero cells and CHO cell mutants deficient in Gag synthesis.
- Inhibition of viral infectivity by HBD peptides was evaluated.
Main Results:
- A single linear heparin-binding domain (HBD) was identified for RSV subgroup A (184A-->T198) and B (183K-->K197).
- Peptide binding to cells was inhibited by heparin and significantly reduced in Gag-deficient cells.
- RSV-G HBD peptides inhibited homologous and heterologous RSV infectivity.
Conclusions:
- The identified sequence (184A/183K-->198T/K197) is a critical determinant of RSV-G interaction with heparin.
- This HBD plays a significant role in RSV attachment and subsequent cell entry.
Abstract:
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract disease in infants and young children worldwide. Infection is mediated, in part, by an initial interaction between attachment protein (G) and a highly sulfated heparin-like glycosaminoglycan (Gag) located on the cell surface. Synthetic overlapping peptides derived from consensus sequences of the G protein ectodomain from both RSV subgroups A and B were tested by heparin-agarose affinity chromatography for their abilities to bind heparin. This evaluation identified a single linear heparin binding domain (HBD) for RSV subgroup A (184A-->T198) and B (183K-->K197). The binding of these peptides to Vero cells was inhibited by heparin. Peptide binding to two CHO cell mutants (pgsD-677 and pgsA-745) deficient in heparan sulfate or total Gag synthesis was decreased 50% versus the parental cell line, CHO-K1, and decreased an average of 87% in the presence of heparin. The RSV-G HBD peptides were also able to inhibit homologous and heterologous virus infectivity of Vero cells. These results indicate that the sequence 184A/183K-->198T/K197 for RSV subgroups A and B, respectively, defines an important determinant of RSV-G interactions with heparin.
Related Concept Videos
Coronavirus
Respiratory Syncytial Virus Disease
Inhibitors Of Virion Release

